<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">41673</article-id><article-id pub-id-type="doi">10.7554/eLife.41673</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Genetic effects on promoter usage are highly context-specific and contribute to complex traits</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-113614"><name><surname>Alasoo</surname><given-names>Kaur</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1761-8881</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121103"><name><surname>Rodrigues</surname><given-names>Julia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121104"><name><surname>Danesh</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121105"><name><surname>Freitag</surname><given-names>Daniel F</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-121106"><name><surname>Paul</surname><given-names>Dirk S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8230-0116</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121107"><name><surname>Gaffney</surname><given-names>Daniel J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Institute of Computer Science</institution>, <institution>University of Tartu</institution>, <addr-line><named-content content-type="city">Tartu</named-content></addr-line>, <country>Estonia</country></aff><aff id="aff2"><institution content-type="dept">Cellular Genetics</institution>, <institution>Wellcome Sanger Institute</institution>, <addr-line><named-content content-type="city">Hinxton</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Department of Public Health and Primary Care</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-94270"><name><surname>Parker</surname><given-names>Stephen</given-names></name><role>Reviewing editor</role><aff><institution>University of Michigan</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>kaur.alasoo@ut.ee</email> (KA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>01</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e41673</elocation-id><history><date date-type="received"><day>05</day><month>09</month><year>2018</year></date><date date-type="accepted"><day>08</day><month>01</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Alasoo et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Alasoo et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-41673-v1.pdf"/><abstract><p>Genetic variants regulating RNA splicing and transcript usage have been implicated in both common and rare diseases. Although transcript usage quantitative trait loci (tuQTLs) have been mapped across multiple cell types and contexts, it is challenging to distinguish between the main molecular mechanisms controlling transcript usage: promoter choice, splicing and 3ʹ end choice. Here, we analysed RNA-seq data from human macrophages exposed to three inflammatory and one metabolic stimulus. In addition to conventional gene-level and transcript-level analyses, we also directly quantified promoter usage, splicing and 3ʹ end usage. We found that promoters, splicing and 3ʹ ends were predominantly controlled by independent genetic variants enriched in distinct genomic features. Promoter usage QTLs were also 50% more likely to be context-specific than other tuQTLs and constituted 25% of the transcript-level colocalisations with complex traits. Thus, promoter usage might be an underappreciated molecular mechanism mediating complex trait associations in a context-specific manner.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>WT09805</award-id><principal-award-recipient><name><surname>Alasoo</surname><given-names>Kaur</given-names></name><name><surname>Rodrigues</surname><given-names>Julia</given-names></name><name><surname>Gaffney</surname><given-names>Daniel J</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000274</institution-id><institution>British Heart Foundation</institution></institution-wrap></funding-source><award-id>RG/13/13/30194</award-id><principal-award-recipient><name><surname>Danesh</surname><given-names>John</given-names></name><name><surname>Freitag</surname><given-names>Daniel F</given-names></name><name><surname>Paul</surname><given-names>Dirk S</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Estonian Research Council</institution></institution-wrap></funding-source><award-id>MOBJD67</award-id><principal-award-recipient><name><surname>Alasoo</surname><given-names>Kaur</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>WT099754/Z/12/Z</award-id><principal-award-recipient><name><surname>Alasoo</surname><given-names>Kaur</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Estonian Research Council</institution></institution-wrap></funding-source><award-id>IUT34-4</award-id><principal-award-recipient><name><surname>Alasoo</surname><given-names>Kaur</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>WT098503</award-id><principal-award-recipient><name><surname>Gaffney</surname><given-names>Daniel J</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>British Heart Foundation Cambridge Centre of Excellence</institution></institution-wrap></funding-source><award-id>RE/13/6/30180</award-id><principal-award-recipient><name><surname>Danesh</surname><given-names>John</given-names></name><name><surname>Freitag</surname><given-names>Daniel F</given-names></name><name><surname>Paul</surname><given-names>Dirk S</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/L003120/1</award-id><principal-award-recipient><name><surname>Danesh</surname><given-names>John</given-names></name><name><surname>Freitag</surname><given-names>Daniel F</given-names></name><name><surname>Paul</surname><given-names>Dirk S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Daniel F Freitag, Since October 2015, Daniel F. Freitag has been a full-time employee of Bayer AG, Germany.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Human induced pluripotent stem cells (iPSCs) lines from 123 healthy donors (72 female and 51 male) (Supplementary file 1) were obtained from the HipSci project (Kilpinen et al., 2017). Of these lines, 57 were initially grown in feeder-dependent medium and 66 were grown in feeder-free E8 medium. The cell lines were screened for mycoplasma by the HipSci project (Kilpinen et al., 2017). All samples for the HipSci project (Kilpinen et al., 2017) were collected from consented research volunteers recruited from the NIHR Cambridge BioResource (http://www.cambridgebioresource.org.uk). Samples were initially collected under ethics for iPSC derivation (REC Ref: 09/H0304/77, V2 04/01/2013), which require managed data access for all genetically identifying data. Later samples were collected under a revised consent (REC Ref: 09/H0304/77, V3 15/03/2013) under which all data, except from the Y chromosome from males, can be made openly available. The ethics approval was obtained from East of England - Cambridge East Research Ethics Committee. The iPSC lines used in this study are commercially available via the European Collection of Authenticated Cell Cultures. No new primary human samples were collected for this study.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>RNA-seq data from the acLDL stimulation study is available from ENA (PRJEB20734) and EGA (EGAS00001000876). RNA-seq data from the IFNɣ + Salmonella study is available from ENA (PRJEB18997) and EGA (EGAS00001002236). The imputed genotype data for HipSci cell lines is available from ENA (PRJEB11749) and EGA (EGAD00010000773). Processed data and QTL summary statistics are available from Zenodo: https://zenodo.org/communities/macrophage-tuqtls/.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Alasoo K</collab><collab>Rodrigues J</collab><collab>Danesh J</collab><collab>Freitag DF</collab><collab>Paul DS</collab><collab>Gaffney DJ</collab></person-group><year iso-8601-date="2017">2017</year><source>Genetic effects on promoter usage are highly context-specific and contribute to complex traits</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/data/view/PRJEB20734">https://www.ebi.ac.uk/ena/data/view/PRJEB20734</ext-link><comment>European Nucleotide Archive, PRJEB20734</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Alasoo K</collab><collab>Rodrigues J</collab><collab>Danesh J</collab><collab>Freitag DF</collab><collab>Paul DS</collab><collab>Gaffney DJ</collab></person-group><year iso-8601-date="2017">2017</year><source>Genetic effects on promoter usage are highly context-specific and contribute to complex traits</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001000876">https://www.ebi.ac.uk/ega/studies/EGAS00001000876</ext-link><comment>European Genome-phenome Archive, EGAS00001000876</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Alasoo K</collab><collab>Rodrigues J</collab><collab>Mukhopadhyay S</collab><collab>Knights AJ</collab><collab>Mann AL</collab><collab>Kundu K</collab><collab>Hale C</collab><collab>Dougan G</collab><collab>Gaffney DJ</collab></person-group><year iso-8601-date="2017">2017</year><source>Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/data/view/PRJEB18997">https://www.ebi.ac.uk/ena/data/view/PRJEB18997</ext-link><comment>European Nucleotide Archive, PRJEB18997</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Alasoo K</collab><collab>Rodrigues J</collab><collab>Mukhopadhyay S</collab><collab>Knights AJ</collab><collab>Mann AL</collab><collab>Kundu K</collab><collab>Hale C</collab><collab>Dougan G</collab><collab>Gaffney DJ</collab></person-group><year iso-8601-date="2017">2017</year><source>Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001002236">https://www.ebi.ac.uk/ega/studies/EGAS00001002236</ext-link><comment>European Genome-phenome Archive, EGAS00001002236</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Kilpinen H</collab><collab>Goncalves A</collab></person-group><year iso-8601-date="2017">2017</year><source>Common genetic variation drives molecular heterogeneity in human iPSCs</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/data/view/PRJEB11749">https://www.ebi.ac.uk/ena/data/view/PRJEB11749</ext-link><comment>European Nucleotide Archive, PRJEB11749</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Kilpinen H</collab><collab>Goncalves A</collab></person-group><year iso-8601-date="2017">2017</year><source>Common genetic variation drives molecular heterogeneity in human iPSCs</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ega/datasets/EGAD00010000773">https://www.ebi.ac.uk/ega/datasets/EGAD00010000773</ext-link><comment>European Genome-phenome Archive, EGAD00010000773</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-41673-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>